Affiliations: [a]
Folkhälsan Research Center, Helsinki, Finland
| [b] Department of Medical Genetics, Medicum, University of Helsinki, Helsinki, Finland
| [c] Dipartimento di Medicina di Precisione, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy
| [d]
Telethon Institute of Genetics and Medicine, Pozzuoli, Italy
| [e]
Institute of Biotechnology, University of Helsinki, Helsinki, Finland
| [f]
Vaasa Central Hospital, Vaasa, Finland
Correspondence:
[*]
Correspondence to: Marco Savarese, Ph.D., Folkhälsan Institute of Genetics, Department of Medical Genetics, University of Helsinki, Biomedicum, Haartmaninkatu 8 -Pb 63 00014 Helsinki, Finland. Tel.: +358 294125069; E-mail: marco.savarese@helsinki.fi.
Note: [1] These authors contributed equally to the work.
Abstract: Although DNA-sequencing is the most effective procedure to achieve a molecular diagnosis in genetic diseases, complementary RNA analyses are often required. Reverse-Transcription polymerase chain reaction (RT-PCR) is still a valuable option when the clinical phenotype and/or available DNA-test results address the diagnosis toward a gene of interest or when the splicing effect of a single variant needs to be assessed. We use Single-Molecule Real-Time sequencing to detect and characterize splicing defects and single nucleotide variants in well-known disease genes (DMD, NF1, TTN). After proper optimization, the procedure could be used in the diagnostic setting, simplifying the workflow of cDNA analysis.
Keywords: Long-read sequencing, single molecule real time, PacBio, splicing